The complexities of homozygous familial hypercholesterolemia management
Author:
Affiliation:
1. Nemours Cardiac Center; Wilmington DE USA
Publisher
Wiley
Subject
Transplantation,Pediatrics, Perinatology and Child Health
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/petr.12812/fullpdf
Reference9 articles.
1. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society;Cuchel;Eur Heart J,2014
2. The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association;Gidding;Circulation,2015
3. Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy;Raal;Circulation,2011
4. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel;Santos;Lancet Diabetes Endocrinol,2016
5. Homozygous autosomal dominant hypercholesterolaemia: prevalence, diagnosis, and current and future treatment perspectives;Sjouke;Curr Opin Lipidol,2015
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Acute coronary syndrome in an 8-year-old child with familial hypercholesterolemia: a case report;Journal of Medical Case Reports;2022-07-26
2. Familial hypercholesterolemia class II low density lipoprotein-receptor response to statin treatment;Disease Models & Mechanisms;2020-01-01
3. Familial hypercholesterolemia with early coronary atherosclerotic heart disease: A case report;Experimental and Therapeutic Medicine;2019-06-10
4. Review of the scientific evolution of gene therapy for the treatment of homozygous familial hypercholesterolaemia: past, present and future perspectives;Journal of Medical Genetics;2019-03-15
5. CRISPR correction of a homozygous low-density lipoprotein receptor mutation in familial hypercholesterolemia induced pluripotent stem cells;Hepatology Communications;2017-10-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3